The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders

Department of Pathology & Cell Biology, Columbia University, College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032, USA.
Gastroenterology (Impact Factor: 16.72). 02/2007; 132(1):397-414. DOI: 10.1053/j.gastro.2006.11.002
Source: PubMed


Serotonin is an important gastrointestinal signaling molecule. It is a paracrine messenger utilized by enterochromaffin (EC) cells, which function as sensory transducers. Serotonin activates intrinsic and extrinsic primary afferent neurons to, respectively, initiate peristaltic and secretory reflexes and to transmit information to the central nervous system. Serotonin is also a neurotransmitter utilized by a system of long descending myenteric interneurons. Serotonin is synthesized through the actions of 2 different tryptophan hydroxylases, TpH1 and TpH2, which are found, respectively, in EC cells and neurons. Serotonin is inactivated by the serotonin reuptake transporter (SERT)-mediated uptake into enterocytes or neurons. The presence of many serotonin receptor subtypes enables selective drugs to be designed to therapeutically modulate gastrointestinal motility, secretion, and sensation. Current examples include tegaserod, a 5-HT(4) partial agonist, which has been approved for treatment of irritable bowel syndrome (IBS) with constipation in women and for chronic constipation in men and women. The 5-HT(3) antagonists, granisetron and ondansetron, are useful in combating the nausea associated with cancer chemotherapy, and alosetron is employed in the treatment of IBS with diarrhea. Serotonergic signaling abnormalities have also been putatively implicated in the pathogenesis of functional bowel diseases. Other compounds, for which efficacy has not been rigorously established, but which may have value, include tricyclic antidepressants and serotonin selective reuptake inhibitors to combat IBS, and 5-HT(1) agonists, which enhance gastric accommodation, to treat functional dyspepsia. The initial success encountered with serotonergic agents holds promise for newer and more potent insights and therapies of brain-gut disorders.

  • Source
    • "Its action is then terminated by uptake into cells through the serotonin transporter (SERT, Slc6a4) (Wade et al., 1996). Thus, serotonin is commonly thought to act locally in neural and paracrine circuits, and its functions vary depending on the tissues (Gershon and Tack, 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Whole body energy balance is achieved through the coordinated regulation of energy intake and energy expenditure in various tissues including liver, muscle and adipose tissues. A positive energy imbalance by excessive energy intake or insufficient energy expenditure results in obesity and related metabolic diseases. Although there have been many obesity treatment trials aimed at the reduction of energy intake, these strategies have achieved only limited success because of their associated adverse effects. An ancient neurotransmitter, serotonin is among those traditional pharmacological targets for anti-obesity treatment because it exhibits strong anorectic effect in the brain. However, recent studies suggest the new functions of peripheral serotonin in energy homeostasis ranging from the endocrine regulation by gut-derived serotonin to the autocrine/paracrine regulation by adipocyte-derived serotonin. Here, we discuss the role of serotonin in the regulation of energy homeostasis and introduce peripheral serotonin as a possible target for anti-obesity treatment.
    Preview · Article · Dec 2015 · Moleculer Cells
  • Source
    • "5-Hydroxytryptamine (5-HT, serotonin) is a neurotransmitter synthesized in the central nervous system, which is involved in numerous physiological responses and behavioral disorders (Filip and Bader, 2009). In non-neural tissues, 5-HT is synthesized, stored, and released mainly by enterochromaffin cells (Gershon and Tack, 2007). The majority of 5-HT released into the blood is captured by and stored in platelets, from which it can be released in any organ (Duerschmied et al., 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: There is mounting evidence that 5-hydroxytryptamine (5-HT) plays a role in asthma. However, scarce information exists about the pulmonary expression of 5-HT receptors and its modification after allergic sensitization. In the present work, we explored the expression of 5-HT1A, 5-HT2A, 5-HT3, 5-HT4, 5-ht5a, 5-HT6, and 5-HT7 receptors in lungs from control and sensitized guinea pigs through qPCR and Western blot. In control animals, mRNA from all receptors was detectable in lung homogenates, especially from 5-HT2A and 5-HT4 receptors. Sensitized animals had decreased mRNA expression of 5-HT2A and 5-HT4 receptors and increased that of 5-HT7 receptor. In contrast, they had increased protein expression of 5-HT2A receptor in bronchial epithelium and of 5-HT4 receptor in lung parenchyma. The degree of airway response to the allergic challenge was inversely correlated with mRNA expression of the 5-HT1A receptor. In summary, our results showed that major 5-HT receptor subtypes are constitutively expressed in the guinea pig lung, and that allergic sensitization modifies the expression of 5-HT2A, 5-HT4, and 5-HT7 receptors.
    Full-text · Article · Dec 2015 · Respiratory Physiology & Neurobiology
  • Source
    • "5-HT 3 RECEPTORS AND VAGAL SENSORY FUNCTIONS 5-HT is an important neurotransmitter in several GI functions, and >90% of the total body 5-HT is contained with the GI tract, either within specialized enteroendocrine cells, termed enterochromaffin (EC) cells or within neurons. Excellent recent reviews have provided in depth coverage of the role of 5-HT within the GI tract (Gershon and Tack, 2007; Mawe and Hoffman, 2013); this review, therefore, will concentrate on the role of 5- HT 3 receptors in gut-brain and brain-gut signaling outside the GI tract itself. Electrophysiological studies have demonstrated functionally active 5-HT 3 receptors on vagal afferent neurons and fibers (Leal-Cardoso et al., 1993; Hillsley et al., 1998; Kreis et al., 2002; Moore et al., 2002; Lacolley et al., 2006a; Babic et al., 2012) and activation of 5-HT 3 receptors induces a short latency, transient increase in firing rate of vagal afferents (Hillsley and Grundy, 1998; Hillsley et al., 1998) or a brief, rapid inward current (or membrane depolarization), in isolated neurons (Leal- Cardoso et al., 1993; Peters et al., 1993; Babic et al., 2012) consistent with its function as a ligand-gated cation channel (Derkach et al., 1989). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Vagal neurocircuits are vitally important in the co-ordination and modulation of GI reflexes and homeostatic functions. 5-hydroxytryptamine (5-HT; serotonin) is critically important in the regulation of several of these autonomic gastrointestinal (GI) functions including motility, secretion and visceral sensitivity. While several 5-HT receptors are involved in these physiological responses, the ligand-gated 5-HT3 receptor appears intimately involved in gut-brain signaling, particularly via the afferent (sensory) vagus nerve. 5-HT is released from enterochromaffin cells in response to mechanical or chemical stimulation of the GI tract which leads to activation of 5-HT3 receptors on the terminals of vagal afferents. 5-HT3 receptors are also present on the soma of vagal afferent neurons, including GI vagal afferent neurons, where they can be activated by circulating 5-HT. The central terminals of vagal afferents also exhibit 5-HT3 receptors that function to increase glutamatergic synaptic transmission to second order neurons of the nucleus tractus solitarius within the brainstem. While activation of central brainstem 5-HT3 receptors modulates visceral functions, it is still unclear whether central vagal neurons, i.e., nucleus of the tractus solitarius (NTS) and dorsal motor nucleus of the vagus (DMV) neurons themselves also display functional 5-HT3 receptors. Thus, activation of 5-HT3 receptors may modulate the excitability and activity of gastrointestinal vagal afferents at multiple sites and may be involved in several physiological and pathophysiological conditions, including distention- and chemical-evoked vagal reflexes, nausea, and vomiting, as well as visceral hypersensitivity.
    Full-text · Article · Oct 2015 · Frontiers in Neuroscience
Show more